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Background In African settings with poor access to health care, surveillance and
surveys of disease burden are often done through home visits. The
optimal recall period to capture data on symptoms and health uti-
lization is unknown.
Methods We collected illness data among 53000 people during fortnightly
home visits in rural and urban Kenya. Dates of cough, fever and
diarrhoea in the past 2 weeks and health-seeking behaviour were
recorded. Incidence rates were modelled using Poisson regression
for data collected from 1 July 2006 to 30 June 2007.
Results Incidence rates were higher in days 0–6 before the home visit
than in days 7–13 before the home visit for all three symptoms,
for the rural and urban sites, for children and adults, for self- and
proxy-reported symptoms and for severe and non-severe illness in
children. Recall decay was steeper in the rural than the urban sites,
and for proxy- than self-reported symptoms. The daily prevalence of
symptoms fell <80% of the maximum prevalence when asking
about symptoms 43 days before the home visit for children and
44 days for persons 55 years of age. Recall of previously docu-
mented clinic visits, and prescriptions of antimalarials and anti-
biotics also declined by 7, 15 and 23% per week, respectively, in
children aged <5 years, and 6, 20 and 16%, respectively, in older
persons (P<0.0001 for each decline).
Conclusions A 2-week recall period underestimates true disease rates and
health-care utilization. Shorter recall periods of 3 days in children
and 4 days in adults would likely yield more accurate data.
Keywords Africa, diarrhoea, fever, memory recall, population surveillance,
respiratory infections
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450Introduction
Defining the disease burden of major infectious
diseases in developing countries is important for
public health policymakers when allocating limited
resources. Most commonly, incidence and prevalence
of disease are defined at health facilities. However,
in sub-Saharan Africa, health facility utilization is
limited. The majority of cases of infectious diseases
in Kenya do not present at health facilities.
1,2
Because of underutilization of health facilities, alter-
native approaches have been employed to define dis-
ease burden in developing country settings. One
method is cross-sectional health utilization surveys
performed at the community level to estimate rates
and health seeking for various diseases. Another
method is to make regular home visits and ask
about symptoms of recent illness. Although more
resource intensive, home-based surveillance yields
longitudinal data with the added benefits of being
able to evaluate seasonality, to define both the inci-
dence and prevalence and to evaluate the impact of
interventions on disease occurrence.
3,4
An important consideration in carrying out
home-based surveillance for infectious diseases is
the optimal recall period for illness. A 2-week recall
has been used in the majority of studies and surveys,
including Demographic and Health Surveys (DHSs)
undertaken every 5 years in many developing coun-
tries.
2,3,5 A 2-week interval of recall, however, seems
to be one chosen more as a compromise between
logistics, cost and data quality, rather than one
based on accuracy alone.
5 Better definition of the
effect of recall time on the reporting of symptoms
might lead to more reliable estimates of true disease
burden and health-utilization patterns.
Since 2005, the Centers for Disease Control and
Prevention (CDC) and the Kenya Medical Research
Institute (KEMRI) have maintained population-based
surveillance for major infectious disease syndromes in
defined populations of rural western Kenya and an
urban informal settlement in Nairobi. The objectives
of the surveillance are to define disease burden,
describe epidemiologic patterns of disease and evalu-
ate the health impact of interventions over time in
these populations. To achieve this, disease is charac-
terized in the clinic, as well as through home visits.
Field workers make home visits every 2 weeks and
ask about recent symptoms. These longitudinal
home visits allowed us to evaluate the effect of
recall period on reporting of symptoms, clinic visita-
tion and drug use. This information on recall is
important in interpreting the surveillance data.
Materials and methods
Surveillance sites
The CDC’s International Emerging Infections
Program, in collaboration with KEMRI, has conducted
population-based, morbidity surveillance since late
2005 at two sites in Kenya. Asembo is a rural loca-
tion in Bondo District of western Kenya along
Lake Victoria. The surveillance population numbers
approximately 25000 in 33 villages. All study partici-
pants must have resided permanently in the area
for 4 calendar months and have been registered into
the KEMRI/CDC Demographic Surveillance System
(DSS).
6,7 The population is predominantly subsistence
farmers and fishermen belonging to the Luo ethnic
group. Houses are widely dispersed in a bushy land-
scape cultivated with small fields. The area comprises
100 km
2 with an overall population density of about
325 persons per square kilometre. Malaria transmis-
sion is endemic and occurs year round.
7 The area had
a child (<5 years of age) mortality ratio of 227 per
1000 live births in 2002.
6 Asembo has high HIV
seroprevalence rates—11% in men and 21% in
women aged 13–34 years in 2003.
8
The other site, with approximately 28000 partici-
pants, is in Gatwikira and Soweto villages in the
Kibera informal settlement of Nairobi, one of the
largest contiguous urban slums in Africa. The surveil-
lance area comprises 0.42km
2 and has a population
density of about 65000 persons per square kilometre.
Most employed residents are casual labourers, ser-
vants, security guards or small-business merchants
within the city. The area has a maze-like array of
semi-permanent housing, with dirt paths between
the dwellings and open sewers. Malaria is not ende-
mic due to the high altitude, although cases of
malaria are frequent among people arriving from
other parts of Kenya. HIV prevalence among adults
is 15% (KEMRI/CDC data). As with the Asembo
site, participants must have resided in Kibera for at
least 4 months prior to enrolment.
In both surveillance sites, participants can access
free health care at centrally located clinics staffed
mostly by study-supported and trained personnel.
Population-based surveillance methods
Community interviewers visit enrolled households
every 2 weeks to inquire about illnesses during the
past 2 weeks. Community interviewers are high-
school graduates without specific health-related train-
ing; however, they undergo intensive protocol-specific
training. They ask each participant a screening ques-
tion, ‘Have you had fever, cough or difficulty in
breathing, diarrhoea, yellow eyes or any other illness
or injury in the past 2 weeks?’. Participants who
answer affirmatively to the screening question are
given a more extensive questionnaire about their ill-
ness. For key symptoms, including cough, fever and
diarrhoea, participants are asked to provide the exact
days in the past 2 weeks when they had those symp-
toms. Other symptoms are categorized as present or
absent. For persons 45 years of age, direct interviews
with the participant are attempted. If not at home or
unable to answer questions for any reason, a proxy
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participant is sought. For children <5 years of age,
the mother, or other knowledgeable caretaker, is
interviewed. Data are collected using personal digital
assistants (PDAs), backed up daily and uploaded onto
a computer every 2 weeks. PDAs are programmed in
Visual Basic dot-Net and data are stored in SQL data-
bases. Regular quality control checks are performed
by data management staff.
Data analysis
For data collected from 1 July 2006 to 30 June 2007,
we modelled incidence rates of illness for fever, diar-
rhoea and cough, using Poisson regression (PROC
GENMOD, SAS version 9.1, SAS Institute, Cary,
NC, USA). We controlled for clustering of symptoms
at the household level using generalizing estimating
equations (GEEs). Incidence rates were calculated
as the number of new episodes of a syndrome per
person-year. We used a symptom-free interval to
define new episodes of the same syndrome. For diar-
rhoea, we used a diarrhoea-free interval of 3 days to
define new episodes.
9–11 For cough and fever, we used
a cough- or fever-free interval of 7 days to define new
episodes.
12 We calculated the denominator using the
person-time contribution of all study participants from
the fortnightly visits. Only days in which a symptom
could be recorded if present were included in the
denominator. For instance, if a person was away at
the time of the fortnightly visit and no suitable proxy
could be found, those 14 days were not included in
the denominator. Likewise, if home visits were made
414 days apart, the intervening days in which no data
on symptoms were collected were not included.
Moreover, only days in which a new episode could
be counted were included in the denominator; there-
fore, subsequent days of an episode after the initial day
and days in the symptom-free interval were excluded
from the denominator.
13 Separate Poisson regression
models were fit for children <5 years and persons
55 years of age. Variables for disease (fever, diar-
rhoea, cough), site (Asembo, Kibera), week (days 0–6
and days 7–13 before interview), site-by-week interac-
tion, site-by-disease interaction and 3-way site-by-
week-by-disease interaction, were included in the
model to allow for estimation and comparison of inci-
dence rates for each combination of disease, site and
week. Incidence rate ratios (RRs) and 95% confidence
intervals (CIs) comparing days 0–6 with days 7–13
before the interview date were calculated. Additional
models were fit for children with inclusion of a vari-
able for severe/non-severe illness, and for persons
55 years of age with inclusion of a variable for
self- vs proxy-report of symptoms.
We compared the recall effect upon severe illnesses
in children to explore whether people tended to better
recall symptoms of severe illnesses. Severe illnesses
were defined for children <5 years of age as those
that included a danger sign, or meeting the severe
pneumonia or severe dehydration criteria, from
WHO’s Integrated Management of Childhood Illness
(IMCI) algorithm.
14 Similar indicators of severity
based on symptoms were not available for adults, so
severity was not assessed in adults. In adults, we
assessed whether recall decay was affected if symp-
toms were reported by the participant him/herself, or
by a proxy.
We assessed the percentage of persons with each
symptom (daily prevalence) on each day of the
14-day recall period for home visits. We arbitrarily
considered days that were 580% of the maximum
daily prevalence rate (day 1 before interview date)
as days in which recall of symptoms was adequate.
We evaluated whether there was recall decay in
reporting of visiting the clinic and of taking anti-
malarial and antibiotic medications using data from
Asembo. To do this, we limited the analysis to those
individuals with a documented visit to the surveil-
lance referral clinic, Lwak Hospital, and to those
who were prescribed and given an anti-malarial and
antibiotic at Lwak Hospital. We looked at the subse-
quent home visit, which could be from 0 to 13 days
after the clinic visit. At the home visit, interviewers
asked whether the participant had visited the clinic
and received anti-malarial and antibiotic medications
in the past 2 weeks. We evaluated whether there was
a decline in the percentage of persons reporting clinic
visits or medication prescription according to the
number of days the home visit followed the clinic
visit with a linear test for trend using log-binomial
regression (PROC GENMOD, SAS version 9.1). Day
0, when the clinic and home visits were on the
same day, was excluded from analysis because the
clinic visit might have followed the home visit on
that day and so would not have been reported.
The head of the household gave informed consent
for home visits. The protocol and consent forms were
reviewed and approved by the Ethical Review Boards
of KEMRI (SSC# 932) and the Institutional Review
Board of CDC (IRB # 4566).
Results
The incidence rates were higher in days 0–6 than in
days 7–13 before the home visit (Table 1). This find-
ing was consistent for all three symptoms, for the
rural and urban sites and for children and adults.
The decay in recall between days 0–6 and days 7–13
before home visit was steeper in the rural than the
urban site for all symptoms and for both children
<5 years and persons 55 years of age, ranging
from 20 to 91% more recall decay in the rural
site (Table 1). Higher incidence was documented in
days 0–6 than days 7–13 before home visit in persons
55 years of age for both self-reported symptoms
(RR 1.67; 95% CI 1.55–1.79) and proxy-reported
symptoms (RR 1.84; 95% CI 1.72–1.97). Recall decay
was 10% lower for self-reported symptoms (Table 2).
452 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYHigher incidence was documented in days 0–6 than
days 7–13 before home visit in children <5 years
of age for both non-severe illness (RR 2.08; 95% CI
1.93–2.25) and severe illness (RR 2.04; 95% CI
1.82–2.28), although there was no difference between
the amount of recall decay in severe and non-severe
illness (Table 2).
Daily prevalence of symptoms increased slightly
from the day of the visit to 1 day before the visit
(Figure 1). This is likely because the day of the visit
was not a complete 24-hday of observation. After
day 1, the daily prevalence decreased slightly during
the next few days, more so in children than adults
(Figure 2). There was a steeper decline in the daily
prevalence of all symptoms in the week before the
home visit among children <5 years of age than
among older children and adults, after which the
daily prevalence continued to decline, but less steeply,
over the following week in both age groups. Daily
prevalence that was 480% of the maximum daily
prevalence, on day 1 before the home visit, was
observed in the 3 days before the home visit in
children and in the 4 days before the home visit in
persons 55 years of age (Figure 2). A similar decay in
the daily prevalence of reported symptoms was found
in the urban site (data not shown).
There was a decrease in the percentage of persons
at the home visit who reported making a clinic visit
and taking anti-malarial and antibiotic medications
with increasing number of days from the clinic visit
(Table 3). This decline was not as steep as that
observed with recall of symptoms. From the first to
the second week after the clinic visit, there was a
reduction in recall of clinic visits, anti-malarial use
and antibiotic use of 7% (95% CI 5–9), 15% (95% CI
11–20) and 23% (95% CI 14–32), respectively, for chil-
dren <5 years of age; for persons 55 years of age, the
reduction in recall was 6% (95% CI 5–7), 20% (95% CI
15–25) and 16% (95% CI 10–22), respectively.
Discussion
Our study demonstrated recall decay of symptoms
to be a robust phenomenon occurring at multiple
levels—for both children and adults, for three key
symptoms, for self-reported and proxy-reported symp-
toms in adults, for severe and non-severe illness
in children and in rural and urban African settings.
This finding suggests that rates of diseases identified
in different studies might vary as a result of not only
differing demographics, environmental conditions and
case definitions, but also differences in the recall
period used.
3,4
Previous studies on recall decay focused on children
in single study sites and all but one on single syn-
dromes.
15–19 In Bangladesh, there was a 34% decrease
in diarrhoea episodes among toddlers reported 48h
prior to the interview time.
15 In India, the proportion
of infants in whom diarrhoea was reported was
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thereafter showing a steady decline with a 15, 26
and 45% decrease in the proportion of children with
diarrhoea reported on days 3, 6 and 7–13, respectively,
before the interview date.
19 Under-reporting of diar-
rhoea episodes has also been shown to occur if the
recall period is 42–3 days in DHS surveys that ask
about diarrhoea in the past 2 weeks.
16 A study from
the Gambia that carried out weekly visits showed a
50% decrease in the symptoms of diarrhoea,
fever and respiratory illness among infants between
the day of the visit and 8 days before.
17 Another study
of maternal recall of symptoms of acute respiratory
illness showed that the specificity of the symptoms
recalled was better 2 weeks after the diagnosis than
4 weeks after.
18
The findings of our study have implications for
designing studies to define the rate of disease using
surveillance methods based on recall of symptoms.
The period of recall should probably not extend
back 43 days for children and 44 days for adults to
achieve a rate that is at least 80% of the possible
maximum rate. To achieve complete ascertainment
of symptoms during longer time periods, more fre-
quent visits than fortnightly or weekly visits should
be considered. More frequent household visits have
been made in some studies, but are resource intensive
and likely to lead to participant fatigue over
time.
3,11,20–22
An alternative strategy to continuous morbidity sur-
veillance for defining disease rates is to record symp-
toms in only a fraction of days.
23,24 Sampling at 7- or
14-day intervals, asking about symptoms 24–48h
before the visit, was shown to result in a relatively
small loss of precision when estimating longitudinal
prevalence of diarrhoeal disease, requiring only small
increases in sample size.
24 Our data suggest that the
precision of such intermittent sampling strategies
might be increased by using 3–4-day recall periods
without compromising accuracy too much. However,
the interval of sampling was sensitive to the duration
of the disease episodes, and so intermittent sampling
might apply more to measurements of longitudinal
prevalence than incidence.
23,24 If periods of recall
43–4 days are considered, mnemonics such as symp-
tom diaries might be employed to minimize recall
decay, although the compliance and accuracy with
such devices in populations with low literacy have
been questioned.
17,25
To our knowledge, this is the first report of recall
decay for clinic visitation and drug use. This finding
has implications for surveys assessing health-seeking
patterns and drug use in communities, such as the
DHSs, which ask about clinic use and medications
in the past 2 weeks. If a recall period of 41 week is
used, clinic utilization and drug use will likely be
underestimated. Recall of antibiotic use was lower
than anti-malarial use likely because anti-malarials
are more recognizable by name than are antibiotics
in rural western Kenya.
Our study evaluated the impact of several different
factors on symptom recall that shed light on how
human memory of symptoms works. First, we
showed that proxy-reported symptoms have steeper
recall decay than self-reported symptoms, which
would be expected since individuals remember their
own experiences better than other people do.
26
Secondly, we found that people in the urban setting
seemed to remember their symptoms better than
people in the rural setting. The reason for this is not
Table 2 Evaluation of specific factors related to recall decay
a
Interaction variables
(second variable
listed is referent)
Children <5
years of age
Ratio of RRs comparing
days 0–6 with days 7–13
before home visit (95% CI)
Persons 55 years of age
Ratio of RRs
comparing days 0–6
with days 7–13 before
home visit (95% CI)
Syndromes
b in Asembo
Diarrhoea vs fever 0.67 (0.62–0.73) 0.84 (0.79–0.90)
Cough vs fever 0.97 (0.92–1.03) 0.84 (0.82–0.87)
Cough vs diarrhoea 1.45 (1.32–1.58) 1.00 (0.94–1.07)
Syndromes in Kibera
Diarrhoea vs fever 0.89 (0.80–0.98) 0.96 (0.84–1.10)
Cough vs fever 0.87 (0.80–0.95) 0.81 (0.75–0.87)
Cough vs diarrhoea 0.98 (0.89–1.09) 0.84 (0.73–0.96)
Self vs proxy Not applicable 0.90 (0.87–0.94)
Severe vs non-severe illness 0.98 (0.89–1.07) Not applicable
aAsembo, rural western Kenya and Kibera, Urban Nairobi. Data from 1 July 2006 to 30 June 2007. Factors were evaluated as
interaction terms in Poisson regression model.
bSyndromes are shown separately for Asembo and Kibera due to significant interaction between syndrome and site in the
model.
454 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYclear, but it could be related to the urban population
being more educated and aware of dates due to sala-
ried employment, compared with the rural setting
where most persons are subsistence farmers.
Alternatively, because rates of reported disease are
higher in the rural setting, recall of separate episodes
of similar illness might be more difficult, a phenom-
enon that has been shown.
26 Our study did not
support the so-called ‘salient principle’, whereby
more severe symptoms are remembered longer than
milder symptoms, which has been observed before,
although the finding is not consistent across stud-
ies.
5,17 Lastly, our data show that recall seemed
to drop precipitously 1 week before home visit,
suggesting that recall of symptoms might be packaged
into week blocks, rather than in days.
Symptom recall by participants might have been
biased by several aspects of human memory.
26 First,
‘telescoping’ of memory, in which events are remem-
bered to have occurred more recently than they actu-
ally did, could have occurred.
26,27 It is possible that
symptoms that occurred 7–13 days before the home
visit might have been recalled as having occurred
during days 0–6 before home visit, thereby falsely
elevating the rates calculated for the last week. This
phenomenon of telescoping has been documented
with events occurring over longer periods of recall of
months or years and might not tend to occur as
markedly in a 2-week recall period, particularly
during the past 3–4 days. Secondly, people tend not
to remember dates as well as events in an auto-
biographical sequence.
26 Therefore, by asking partici-
pants to remember symptoms in relation to a personal
event, such as a market day or a church day, rather
than in a 2-week period, might have led to greater
accuracy of recall, particularly for less recent symp-
toms. Lastly, participants might have tended to
over-report symptoms because they wanted to be
‘helpful’ interviewees, whereas on the other hand
they might have under-reported symptoms due to
interview fatigue during longitudinal surveillance.
26,28
Although both of these occurrences might have
yielded inaccurate rates of disease, they would likely
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Figure 1 Daily prevalence of (A) fever, (B) diarrhoea
(C) and cough calculated as percentage of persons reporting
symptoms on each day in the 2 weeks prior to home visit,
Asembo, western Kenya. Data from 1 July 2006 to 30 June
2007.
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Figure 2 Relative symptom prevalence of fever, diarrhoea
and cough compared with day 1 as reference, Asembo,
western Kenya. Data from 1 July 2006 to 30 June 2007.
Line demarcates 80% of maximum prevalence.
EVALUATION OF THE OPTIMAL RECALL PERIOD FOR DISEASE SYMPTOMS 455not have affected this analysis of recall as they would
have been unlikely to have been differential with
respect to symptom recall period.
In conclusion, because of under-utilization of health
facilities, defining disease burden in developing coun-
try settings can be more complete when asking per-
sons to recall symptoms of recent illnesses during
home visits. Recall of symptoms is greatly influenced
by the time period of recall. Our data suggest that the
period of recall should not exceed 3 days in children
and 4 days in adults to identify at least 80% of the
maximum rate of disease, particularly for longitudinal
studies involving repetitive visits. Limitations of
symptom recall should be considered in the context
of the logistics and cost of designing a surveillance
system to define the burden of disease in developing
countries.
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Table 3 Recall at the home visit following documented clinic visits at Lwak Hospital
a
n (%) reporting a clinic
visit to Lwak in past 2 weeks
n (%) reporting receiving
antimalarials
b in the
past 2 weeks
n (%) reporting receiving
an antibiotic
b in the
past 2 weeks
Day after clinic
visit that home
visited
Children
<5 years
c
of age
Persons
55 years
c
of age
Children
<5 years
c
of age
Persons
55 years
c
of age
Children
<5 years
c
of age
Persons
55 years
c
of age
0
d 56 (35) 310 (49) 11 (12) 21 (9) 15 (27) 49 (16)
1 139 (94) 531 (96) 59 (77) 129 (69) 35 (65) 132 (52)
2 137 (98) 440 (96) 61 (86) 120 (76) 35 (65) 137 (56)
3 152 (99) 449 (96) 73 (84) 122 (73) 46 (71) 124 (54)
4 125 (96) 433 (96) 74 (85) 110 (71) 36 (71) 107 (49)
5 142 (97) 424 (94) 59 (83) 102 (65) 35 (64) 99 (45)
6 156 (96) 490 (94) 81 (83) 137 (64) 43 (67) 142 (52)
7 170 (98) 561 (94) 78 (74) 169 (66) 48 (74) 168 (55)
8 130 (94) 432 (93) 76 (87) 113 (60) 32 (55) 117 (54)
9 112 (91) 359 (90) 71 (85) 97 (52) 27 (51) 94 (43)
10 142 (89) 374 (89) 78 (77) 104 (56) 34 (48) 98 (39)
11 100 (86) 309 (87) 56 (68) 76 (51) 25 (42) 79 (38)
12 101 (84) 298 (87) 58 (64) 77 (50) 25 (45) 80 (37)
13 137 (86) 441 (84) 68 (51) 125 (50) 25 (42) 114 (35)
aClinic visitation, antimalarial, and antibiotic use based on the day after documented clinic visit at Lwak Hospital that the home
visit was made, Asembo, rural western Kenya. Data from 1 July 2006 to 30 June 2007.
bFor anti-malarial and antibiotic recall, only those individuals with a known prescription given at Lwak hospital were included in
the denominator.
cFor all six columns, the linear test for trend had a P-value <0.0001 for a decrease in recall from days 1–13; day 0 was excluded
(see ‘Methods’ section).
dDay 0 is when the home visit is on the same day as the clinic visit.
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 During home visits, 2-week recall periods of symptoms underestimated true disease incidence, as
suggested by higher incidence of disease reported in Days 0–6 before home visit than in Days 7–13
before home visit.
 The findings were consistent for all symptoms (cough, fever and diarrhoea), age group, site (urban
and rural), severity of illness and proxy- and self-reported symptoms.
 Daily prevalence of symptoms reported at home visits decreased <80% of the maximum recall when
asking about symptoms43 days before the home visit for children and44 days for persons 55 years
of age.
 Reporting of documented clinic visitation, anti-malarial and antibiotic use also decreased as the
number of days between the clinic visit/drug prescription and home visit increased.
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